Overview of changes following BREXIT
The Regulatory team at JensonR+ have been considering the changes to European MR/DC Procedures for medicines following the end of transition period and offer some guidance in this helpful video
Janet is Head of Regulatory at Jenson R+ Ltd and joined the company in April 2019 after running her own consultancy business, consult2deliver limited, based in BioCity Nottingham.
Latest posts by Janet Worrell (see all)
- CAP Grandfathering Update - February 22, 2021
- Overview of changes following BREXIT - February 3, 2021
- CAP Grandfathering Update - December 9, 2020